Medication info

Rostel Tablet 40/20 Milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets (10 tablets/Alu-Alu) x 3
Approval status
Expired

MFDS item code 201506821 · Approved 2015.09.25

This product's status changed to Expired on 2025.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression
Who takes it
Adults
Adult dose
In a drug interaction study of telmisartan 80mg and rosuvastatin 20mg, the active ingredients of this medicine, the Cmax and AUC of telmisartan in the presence of rosuvastatin were approximately 0.87-fold and 1.00-fold, respectively, while the Cmax and AUC of rosuvastatin in the presence of telmisartan increased approximately 1.71-fold and 1.16-fold, respectively. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor patients closely. This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of end-organ damage
  • high-risk diabetes
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
View approved original text

This medication is used only for patients who need to take the two drugs Telmisartan and Rosuvastatin simultaneously. Telmisartan helps in the treatment of essential hypertension and reduces the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction, stroke, and mortality due to cardiovascular diseases in high-risk patients over the age of 55. Rosuvastatin is used as an adjunct to diet in patients with hypercholesterolemia and hyperlipidemia, lowering both total cholesterol and LDL cholesterol levels, thus delaying the progression of atherosclerosis. It is also used in high-risk patients with risk factors for cardiovascular diseases to reduce the risk of stroke, myocardial infarction, and revascularization procedures. Therefore, this medication is used to manage both hypertension and hyperlipidemia in order to improve cardiovascular health.

How to take

Adult dose

In a drug interaction study of telmisartan 80mg and rosuvastatin 20mg, the active ingredients of this medicine, the Cmax and AUC of telmisartan in the presence of rosuvastatin were approximately 0.87-fold and 1.00-fold, respectively, while the Cmax and AUC of rosuvastatin in the presence of telmisartan increased approximately 1.71-fold and 1.16-fold, respectively. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor patients closely. This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during pregnancy. Therefore, if pregnancy is confirmed, use should be discontinued immediately. Women who are allergic to this medication, pregnant women, nursing mothers, or women who may become pregnant should not use this medication. Patients with severely impaired liver function or problems with bile excretion should avoid this medication. This medication is not recommended for patients with very poor kidney function, certain muscle diseases, or a history of angioedema. Elderly patients and those with high potassium levels in the blood need to be cautious when taking this medication, and those with weakened liver or kidney function should use it carefully. This medication may cause muscle-related side effects such as myalgia or muscle weakness, so if such symptoms occur, medical consultation is advised immediately. Liver function abnormalities can occur, so regular liver function tests should be conducted before and during treatment. Since there may be interactions with other medications, it is essential to inform the doctor or pharmacist of any currently taken medications. This medication may cause drowsiness or dizziness, so caution is required when driving or operating machinery. The safety of this medication has not been established in children, pregnant women, or nursing mothers, so it is advisable not to use it in these populations. In case of overdose, hypotension, dizziness, and decreased kidney function may occur. If this happens, seek immediate medical treatment. This medication contains lactose, so individuals with lactose intolerance should use it with caution. While taking this medication, if symptoms like myalgia, weakness, or fever occur, inform a doctor immediately and undergo necessary tests. Women planning to become pregnant should consult a physician before taking this medication and ensure the use of appropriate contraceptive methods. This medication may affect liver and kidney function, so regular tests are needed, and any abnormal symptoms should be reported to healthcare providers immediately.

Side effects

Headache, orthostatic dizziness, sleep paralysis, hypertension, hypotension, low blood pressure, increased ALT, dysuria, rhinitis, pharyngeal discomfort, pulmonary disease, gastrointestinal disease, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver disease, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, asthenia, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum CK, decreased hemoglobin, angioedema, hypovolemia, increased serum potassium, increased serum creatinine, thrombocytopenia, increased serum creatinine, hematuria, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, decreased appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, ear noise, petechiae, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, edema, depression, sleep disturbance, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, palpitations, fatigue, nausea, insufficient effect, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, decreased appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, ear noise, petechiae, angioedema, hypovolemia, increased serum potassium, increased serum creatinine, thrombocytopenia, increased serum creatinine, hematuria, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, decreased appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, ear noise, petechiae, angioedema, hypovolemia, increased serum potassium, increased serum creatinine, thrombocytopenia, increased serum creatinine, hematuria, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, decreased appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, ear noise, petechiae, angioedema, hypovolemia, increased serum potassium, increased serum creatinine, thrombocytopenia, increased serum creatinine, hematuria

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air or moisture from entering, and at a temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.